Mu-Tzu Chu
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- Drug-Induced Adverse Reactions 5
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Wen‐Hung Chung (9 shared papers)Wen‐Hung Chung (7 shared papers)Ren‐You Pan (3 shared papers)Shu-Jen Chen (1 shared paper)Lei Zheng (1 shared paper)Wan‐Chun Chang (3 shared papers)Wei-Chi Wang (1 shared paper)Chun‐Bing Chen (4 shared papers)
- Journals
- Journal of Investigative Dermatology (2 papers)Nature Communications (1 paper)Journal of Immunology Research (1 paper)The American Journal of Chinese Medicine (1 paper)Pharmaceutics (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Mu-Tzu Chu
9 papers receiving 421 citations
Peers
Comparison fields: 5 of 53
- Pharmacology 209
- Immunology 86
- Oncology 70
- Nephrology 16
- Pharmacology 15
Countries citing papers authored by Mu-Tzu Chu
This map shows the geographic impact of Mu-Tzu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Tzu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Tzu Chu more than expected).
Fields of papers citing papers by Mu-Tzu Chu
This network shows the impact of papers produced by Mu-Tzu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Tzu Chu. The network helps show where Mu-Tzu Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Tzu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 106 | |
| 2 | 2018 | 104 | |
| 3 | 2019 | 97 | |
| 4 | 2019 | 51 | |
| 5 | 2023 | 20 | |
| 6 | 2020 | 18 | |
| 7 | 2022 | 17 | |
| 8 | 2020 | 9 | |
| 9 | 2023 | 8 |
About Mu-Tzu Chu
Mu-Tzu Chu is a scholar working on Pharmacology, Immunology, Nephrology, Oncology and Molecular Biology, having authored 9 papers that have together received 430 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (5 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (1 paper), Inflammasome and immune disorders (1 paper), CAR-T cell therapy research (1 paper) and Gout, Hyperuricemia, Uric Acid (1 paper). The work is most often cited by research in Pharmacology (209 citations), Immunology (86 citations), Oncology (70 citations), Nephrology (16 citations) and Pharmacology (15 citations). Mu-Tzu Chu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Hung Chung, Wen‐Hung Chung, Ren‐You Pan, Shu-Jen Chen, Lei Zheng, Wan‐Chun Chang, Wei-Chi Wang, Chun‐Bing Chen, Chuang‐Wei Wang and Chih–Yuan Hsu. Their work appears in journals such as Journal of Investigative Dermatology, Nature Communications, Journal of Immunology Research, The American Journal of Chinese Medicine and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.